Papers
Topics
Authors
Recent
Search
2000 character limit reached

Scaling Arabic Medical Chatbots Using Synthetic Data: Enhancing Generative AI with Synthetic Patient Records

Published 12 Sep 2025 in cs.CL | (2509.10108v1)

Abstract: The development of medical chatbots in Arabic is significantly constrained by the scarcity of large-scale, high-quality annotated datasets. While prior efforts compiled a dataset of 20,000 Arabic patient-doctor interactions from social media to fine-tune LLMs, model scalability and generalization remained limited. In this study, we propose a scalable synthetic data augmentation strategy to expand the training corpus to 100,000 records. Using advanced generative AI systems ChatGPT-4o and Gemini 2.5 Pro we generated 80,000 contextually relevant and medically coherent synthetic question-answer pairs grounded in the structure of the original dataset. These synthetic samples were semantically filtered, manually validated, and integrated into the training pipeline. We fine-tuned five LLMs, including Mistral-7B and AraGPT2, and evaluated their performance using BERTScore metrics and expert-driven qualitative assessments. To further analyze the effectiveness of synthetic sources, we conducted an ablation study comparing ChatGPT-4o and Gemini-generated data independently. The results showed that ChatGPT-4o data consistently led to higher F1-scores and fewer hallucinations across all models. Overall, our findings demonstrate the viability of synthetic augmentation as a practical solution for enhancing domain-specific LLMs in-low resource medical NLP, paving the way for more inclusive, scalable, and accurate Arabic healthcare chatbot systems.

Summary

Paper to Video (Beta)

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 5 tweets with 0 likes about this paper.